Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] data will be publicly presented for the first time earlier on June 24 at the FSHD Society’s International Research Congress. This webinar will be the first presentation of the data […]
[…] have progressed along the path to FDA approval. DUX4 is considered a key gene causing FSHD. The process begins with finding a “target,” or biological disease mechanism, that can be […]
Where to start? Managing FSHD looks different for everyone. Some people focus on exercise and mobility, while others need information on pain management, breathing, or adaptive tools. No matter where […]
[…] a cure. If you haven’t done so already, please take a minute to register as a member. We can’t win this fight without knowing who and where FSHD patients and families are.
We can do more than simply aspire to a treatment in some undefined future. We are confident that, with your continued support, we will have treatments for FSH muscular dystrophy […]
